X

Stay Connected

Sign Up for Updates

We are creating a place where we can share ideas, provide the perspective of America's biopharmaceutical companies and, most importantly, listen to you.

R&D Focus: New report shows nearly 600 medicines in development for pediatric patients

By Andrew Powaleny  |    February 13, 2020
America’s biopharmaceutical researchers are committed to studying, developing and testing medicines to meet the unique needs of pediatric patients. New treatment options for infants, children and...   Read More

New report: Biopharmaceutical industry supports over 4 million jobs and $1.1 trillion in U.S. economic output

By Sarah Sutton  |    February 12, 2020
Across the country, the biopharmaceutical sector supports millions of jobs in its pursuit to discover ground-breaking treatments and cures for patients around the world.   Read More

Trump administration must defend and protect U.S. innovation

By Priscilla VanderVeer  |    February 6, 2020
PhRMA recently submitted comments to the Office of the United States Trade Representative (USTR)’s Special 301 Report, calling on the Trump administration to defend American biopharmaceutical...   Read More

Working together to combat coronavirus

By Richard Moscicki, M.D.  |    February 6, 2020
The World Health Organization (WHO) recently declared the outbreak of 2019-nCoV, a novel strain of coronavirus that originated in Wuhan, China, a global health emergency. In the last three weeks,...   Read More

Search the Catalyst

View Posts by Topic

see all

Subscribe to Email Updates